Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yezi Zou"'
Autor:
Miner Xie, Liwen Zhou, Ting Li, Yujie Lin, Ruhua Zhang, Xianchong Zheng, Cuiling Zeng, Lisi Zheng, Li Zhong, Xiaodan Huang, Yezi Zou, Tiebang Kang, Yuanzhong Wu
Publikováno v:
Advanced Science, Vol 11, Iss 22, Pp n/a-n/a (2024)
Abstract Bladder cancer (BC) is one of the most common tumors characterized by a high rate of relapse and a lack of targeted therapy. Here, YEATS domain‐containing protein 4 (YEATS4) is an essential gene for BC cell viability using CRISPR‐Cas9 li
Externí odkaz:
https://doaj.org/article/137cedf965a7493daa8dbbf0e0e9bef1
Autor:
Yan Yang, Wenyan Gong, Chenxi Jin, Zhiquan Chen, Lei Zhang, Yezi Zou, Shijian Quan, Heqing Huang
Publikováno v:
Journal of Functional Foods, Vol 50, Iss , Pp 53-62 (2018)
Aims: With the specific pharmacological activities including anti-inflammation, anti-oxidant and hypoglycemic effects, Naringin may possess the potential to ameliorate diabetic nephropathy (DN). The purpose of this study was to investigate the anti-D
Externí odkaz:
https://doaj.org/article/8a8dcec58eab4f09bb8cd1af5ef57715
Autor:
Yezi Zou, Zhiquan Chen, Jie Li, Wenyan Gong, Lei Zhang, Futian Xu, Lihao Chen, Peiqing Liu, Heqing Huang
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
BackgroundProgestin and adipoQ receptor 3 (PAQR3), is a Golgi-anchored membrane protein containing seven transmembrane helices. It has been demonstrated that PAQR3 mediates insulin resistance, glucose and lipid metabolism, and inflammation. In additi
Externí odkaz:
https://doaj.org/article/09d891a69abc4a37af19b4a1ea50fd3e
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Diabetic nephropathy (DN) is rapidly becoming the leading cause of end-stage renal disease worldwide and a major cause of morbidity and mortality in patients of diabetes. The main pathological change of DN is renal fibrosis. Paeonol (PA), a single ph
Externí odkaz:
https://doaj.org/article/6e28db1a490941039a56e7565e610b6c
Autor:
Yuanzhong Wu, Liwen Zhou, Yezi Zou, Yijun Zhang, Meifang Zhang, Liping Xu, Lisi Zheng, Wenting He, Kuai Yu, Ting Li, Xia Zhang, Zhenxuan Chen, Ruhua Zhang, Penghui Zhou, Nu Zhang, Limin Zheng, Tiebang Kang
Publikováno v:
Nature Cancer. 4:382-400
Immunotherapies targeting the PD-1/PD-L1 axis have become first-line treatments in multiple cancers. However, only a limited subset of individuals achieves durable benefits because of the elusive mechanisms regulating PD-1/PD-L1. Here, we report that
Autor:
Wenyan Gong, Chenxi Jin, Lei Zhang, Yezi Zou, Yan Yang, Zhiquan Chen, Heqing Huang, Shijian Quan
Publikováno v:
Journal of Functional Foods, Vol 50, Iss, Pp 53-62 (2018)
Aims With the specific pharmacological activities including anti-inflammation, anti-oxidant and hypoglycemic effects, Naringin may possess the potential to ameliorate diabetic nephropathy (DN). The purpose of this study was to investigate the anti-DN
Autor:
Yuanzhong Wu, Ruhua Zhang, Kaishun Hu, Tiebang Kang, Li Zhong, Liwen Zhou, Lisi Zheng, Shang Wang, Xin Wang, Yezi Zou
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-12 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Human single-stranded DNA-binding protein 1 (hSSB1) is required for the efficient recruitment of the MRN complex to DNA double-strand breaks and is essential for the maintenance of genome integrity. However, the mechanism by which hSSB1 recruits NBS1
Publikováno v:
Free Radical Biology and Medicine. 115:338-350
Our previous study indicated that Casein kinase 2 interacting protein-1 (CKIP-1) could promote the activation of the nuclear factor E2-related factor 2 (Nrf2)/ antioxidant response element (ARE) pathway, playing a significant role in inhibiting the f
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO3-6
Autor:
Yezi, Zou, Zhiquan, Chen, Jie, Li, Wenyan, Gong, Lei, Zhang, Futian, Xu, Lihao, Chen, Peiqing, Liu, Heqing, Huang
Publikováno v:
Frontiers in endocrinology. 9
Progestin and adipoQ receptor 3 (PAQR3), is a Golgi-anchored membrane protein containing seven transmembrane helices. It has been demonstrated that PAQR3 mediates insulin resistance, glucose and lipid metabolism, and inflammation. In addition, kidney